John Maher

John Maher

Company: Leucid Bio

Job title: Chief Scientific Officer


Cancer Immunotherapy using TGF-β Conditioned Gamma Delta T-Cells 11:00 am

• TGF-β enhances the yield and intrinsic anti-tumour activity of gd T-cells expanded from peripheral blood • Both unmodified and CAR-engineered cells demonstrate superior anti-tumour activity in a range of disease modelsRead more

day: Track A - Day 2 AM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.